Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does SPIRONOLACTONE Cause Infection susceptibility increased? 40 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 40 reports of Infection susceptibility increased have been filed in association with SPIRONOLACTONE (spironolactone). This represents 0.2% of all adverse event reports for SPIRONOLACTONE.

40
Reports of Infection susceptibility increased with SPIRONOLACTONE
0.2%
of all SPIRONOLACTONE reports
0
Deaths
40
Hospitalizations

How Dangerous Is Infection susceptibility increased From SPIRONOLACTONE?

Of the 40 reports, 40 (100.0%) required hospitalization, and 1 (2.5%) were considered life-threatening.

Is Infection susceptibility increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for SPIRONOLACTONE. However, 40 reports have been filed with the FAERS database.

What Other Side Effects Does SPIRONOLACTONE Cause?

Acute kidney injury (3,273) Hyperkalaemia (2,518) Hypotension (1,583) Dyspnoea (1,468) Drug ineffective (1,379) Hyponatraemia (1,166) Dizziness (991) Fatigue (990) Fall (947) Off label use (899)

What Other Drugs Cause Infection susceptibility increased?

ADALIMUMAB (179) ETANERCEPT (160) OCRELIZUMAB (118) METHOTREXATE (95) PREDNISONE (67) DIMETHYL (64) MYCOPHENOLATE MOFETIL (64) PREDNISOLONE (62) SECUKINUMAB (59) TOFACITINIB (57)

Which SPIRONOLACTONE Alternatives Have Lower Infection susceptibility increased Risk?

SPIRONOLACTONE vs SPRYCEL SPIRONOLACTONE vs STALEVO SPIRONOLACTONE vs STANNOUS FLUORIDE SPIRONOLACTONE vs STANOZOLOL SPIRONOLACTONE vs STAVUDINE

Related Pages

SPIRONOLACTONE Full Profile All Infection susceptibility increased Reports All Drugs Causing Infection susceptibility increased SPIRONOLACTONE Demographics